Javeri Fiscal Services Ltd.

About Javeri

Equity

Derivatives

Mutual Funds

IPO

Corporate Info

Research

Corporate Info

Smart Quotes

Company Background

Board of Directors

Balance Sheet

Profit & Loss

Peer Comparison

Cash Flow

Shareholdings Pattern

Quarterly Results

Share Price

Deliverable Volume

Historical Volume

MF Holdings

Financial Ratios

Directors Report

Price Charts

Beta Analysis

Board Meetings

Corporate Announcements

Book Closure

Bonus

Company News

Dividend Details

Bulk Deals

Insider Trading

Advanced Chart

HOME > CORPORATE INFO > SMART QUOTES

Smart Quotes

Ipca Laboratories Ltd.

Industry : Pharmaceuticals & Drugs

BSE Code	524494
ISIN Demat	INE571A01038
Book Value	265.61

NSE Code	IPCALAB
Dividend Yield %	0.25
Market Cap	401930.91

P/E	61.84
EPS	25.62
Face Value	1


	BSE		NSE

20-Dec-2024

Last Price	1584.25
Net Change	-9.2
% Change	-0.58%
Prev.Close	1593.45
Open	1608.00
High	1616.80
Low	1578.60
Volume	18764

Last Price	1582.50
Net Change	-12.45
% Change	-0.78%
Prev.Close	1594.95
Open	1607.95
High	1616.40
Low	1578.00
Volume	683300

Value	30074401
Best Buy	0.00
Best Sell	0.00
Best Quantity	0
Sell Quantity	0
Today's Range	1616.80
52-Week High	1708.70
52-Week Low	1042.00

Value	1093338387.6
Best Buy	1582.50
Best Sell	0.00
Best Quantity	335
Sell Quantity	0
Today's Range	1616.40
52-Week High	1708.65
52-Week Low	1041.00

Open Price	1594.75
High Price	1616.65
Low Price	1578.85
Last Price	1584.05
Prev Close	1595.10
Change	-11.05
% Change	-0.69 %

Average Price	1599.86
Underlying Value	1582.50
Number of contracts traded	2674
Turnover in Rs. Lakhs	27807
Open Interest	2059200.00
Change in O I	-567450.00
% Change in O I	-21.60 %

Today

You need to upgrade your Flash Player

Best Bid

Best Offer

Quantity	0
Price	0.00

Quantity	0
Price	0.00

Best Bid

Best Offer

Quantity	335
Price	1582.50

Quantity	0
Price	0.00

Best Bid

Best Offer

Quantity	650
Price	1585.15

Quantity	650
Price	1586.95

Holding Details

Latest Corporate Events

Bonus

1 : 1

28-Jan-05

Book Closure

07-Aug-24

13-Aug-24

Dividend

200 %

27-Nov-24

Company News

05-12-2024

Ipca Laboratories secures...

15-11-2024

Ipca Laboratories informs...

04-10-2024

Ipca Laboratories informs...

23-09-2024

Ipca Laboratories informs...

20-09-2024

Ipca Laboratories informs...

06-09-2024

IPCA Laboratories informs...

19-08-2024

IPCA Laboratories informs...

Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA
Publishing of investor charter information | Annexure A – Investor charter of brokers |
Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source: Click Here.